Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 95 P102 | DOI: 10.1530/endoabs.95.P102

BSPED2023 Poster Presentations Diabetes 3 (12 abstracts)

Prohormone convertase 1/3 deficiency can be associated with diabetes mellitus in childhood

Rachel Varughese 1 , Sasha Howard 2 , Gary Butler 3 & Mehul Dattani 1


1Great Ormond Street Hospital, London, UK; 2William Harvey Research Institute, London, UK; 3University College London Hospital, London, UK


Prohormone convertase 1/3 (PC1/3) deficiency is rare, caused by homozygous or compound heterozygous mutations in the PCSK1 gene. PCSK1 encodes a serine protease important in cleavage of several proneuropeptides and prohormones. Despite a variety of known endocrine associations, paediatric diabetes mellitus is rare, described only once before. Previous understanding was that biological activity of elevated proinsulin (<5% of the activity of insulin) confers protection from diabetes mellitus in childhood, and that diabetes emerges in adulthood through B-cell exhaustion. We present two cases of PC1/3 deficiency with diabetes mellitus onset in childhood. The endocrine manifestations were very similar across the two and are summarised in Table 1.Patient 1Patient 1 was born at term to consanguineous parents (first cousins). Severe malabsorption from week1 required TPN until 7 months old. At 8.5years, he had marked acanthosis, and an OGTT revealed impaired glucose tolerance, with elevated fasting insulin (54.1 mU/L=390 pmol/L) and peak glucose 9.7 mmol/L. Insulin therapy led to hypoglycaemia, so management focussed on metformin/dietary changes. Exome sequencing revealed a novel homozygous PCSK1 nonsense mutation (p.R391*) in the catalytic domain.Patient 2 Patient 2 was born at term to ‘distantly related’ parents. Significant diarrhoea from week 2 required TPN until 7 months old. He developed diabetes mellitus at 11.5years. Insulin therapy prompted recurrent hypoglycaemias leading to challenging glycaemic control, unsuccessful metformin trial and eventual cautious insulin reintroduction.

Table 1
Patient 1Patient 2
HypothyroidismYes-1.5yYes-5y
Hypogonadotrophic-hypogonadismYesYes
HyperphagiaYes-4yYes-3y
ObesityYes-4y-persistedYes-5y-resolved in adolescence
Diabetes insipidusPartial-5yPartial-4y
Growth hormone deficiencyYes-8y-GH commenced, coinciding with diabetes mellitusYes-7y-treatment delayed due to good height velocity, and then poor glycaemic control
Cortisol deficiencyYes-6yYes-7.5y
MRI PituitarySmall anterior pituitary, decreased posterior pituitary signalNormal anterior pituitary, absent posterior pituitary
Final height−0.485−1.42
Current weight z-score+4.39+0.16

Key Learning:

  • Diabetes mellitus in childhood is possible in PC1/3 deficiency, warranting assessment in known cases
  • Diabetes phenotype in both included:
    1. A mixed picture of insulin insensitivity and insulin deficiency
    2. Recurrent hypoglycaemic episodes with insulin (suggesting preservation of insulin sensitivity)
    3. Swinging hypo-/hyperglycaemia (theorised to be related to delayed effects of proinsulin, which has a five-fold longer half-life than insulin).

Volume 95

50th Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Manchester, UK
08 Nov 2023 - 10 Nov 2023

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.